SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-21-118557
Filing Date
2021-04-16
Accepted
2021-04-16 08:32:05
Documents
15
Period of Report
2021-04-16
Items
Item 2.01: Completion of Acquisition or Disposition of Assets
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d179323d8k.htm   iXBRL 8-K 39095
2 EX-99.1 d179323dex991.htm EX-99.1 16950
7 GRAPHIC g179323g0416011245918.jpg GRAPHIC 3792
  Complete submission text file 0001193125-21-118557.txt   231602

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA amgn-20210416.xsd EX-101.SCH 3741
4 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE amgn-20210416_def.xml EX-101.DEF 13563
5 XBRL TAXONOMY EXTENSION LABEL LINKBASE amgn-20210416_lab.xml EX-101.LAB 22601
6 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE amgn-20210416_pre.xml EX-101.PRE 14373
8 EXTRACTED XBRL INSTANCE DOCUMENT d179323d8k_htm.xml XML 6414
Mailing Address ONE AMGEN CENTER DRIVE THOUSAND OAKS CA 91320
Business Address ONE AMGEN CENTER DRIVE THOUSAND OAKS CA 91320 (805)447-1000
AMGEN INC (Filer) CIK: 0000318154 (see all company filings)

IRS No.: 953540776 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-37702 | Film No.: 21830168
SIC: 2836 Biological Products, (No Diagnostic Substances)